Related Experiment Video
Updated: Jan 16, 2026

Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System
Published on: December 11, 2016
Beyond the Forest Plot: Redefining Model-Based Meta-Analysis as a Quantitative Engine for Model-Informed Drug
Bhavatharini Sukumaran1, Rinu Mary Xavier1, Aswathy Vs2
1Department of Pharmacy Practice, JSS College of Pharmacy, JSS Academy of Higher Education & Research, Ooty, Nilgiris, Tamil Nadu, India.
Model-Based Meta-analysis (MBMA) enhances drug development by integrating pharmacometric modeling with traditional meta-analysis. This advanced method provides predictive insights for dose selection and treatment effects, overcoming limitations of standard evidence synthesis.
Area of Science:
- Pharmacometrics
- Clinical Trial Methodology
- Evidence Synthesis
Background:
- Traditional meta-analysis has limitations in drug development, particularly for dose selection and time-course dynamics.
- Model-Based Meta-analysis (MBMA) combines pharmacometric modeling with meta-analysis to address these limitations.
Purpose of the Study:
- To critically assess MBMA as a quantitative tool for model-informed drug development (MIDD).
- To demystify MBMA's methodology, practical applications, and its distinction from traditional meta-analysis.
Main Methods:
- Summarizing and synthesizing major MBMA techniques, including nonlinear mixed-effects modeling and Bayesian hierarchical models.
- Discussing model estimation, validation, and uncertainty quantification.
- Reviewing therapeutic area applications and regulatory considerations.
Main Results:
- MBMA offers predictive information by considering dose-response relationships, longitudinal effects, and between-study heterogeneity.
- MBMA aids in dose optimization, efficacy comparison, pediatric extrapolation, and clinical trial design.
- MBMA translates heterogeneous clinical data into actionable insights for drug development.
Conclusions:
- MBMA is a valuable, though underutilized, technique in model-informed drug development.
- MBMA provides a significant advancement over traditional meta-analysis for quantitative decision-making.
- MBMA is crucial for leveraging clinical data across the drug development lifecycle.
More Related Videos
08:47Experimental Quantification of Interactions Between Drug Delivery Systems and Cells In Vitro: A Guide for Preclinical Nanomedicine Evaluation
Published on: September 28, 2022
09:35A Protocol for Using Gene Set Enrichment Analysis to Identify the Appropriate Animal Model for Translational Research
Published on: August 16, 2017
Related Concept Videos
Mechanistic Models: Overview of Compartment Models
Analysis Methods of Pharmacokinetic Data: Model and Model-Independent Approaches
The model approach uses mathematical models to describe changes in drug concentration over time. Pharmacokinetic models help characterize drug behavior in patients, predict drug concentration in the body fluids, calculate optimum dosage regimens, and evaluate the risk of toxicity. However, ensuring that the model fits the experimental data accurately...
Pharmacokinetic Models: Overview
There are three primary types of models: empirical, compartment, and physiological. Empirical models, with minimal...
Structure-Activity Relationships and Drug Design
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
Mechanistic Models: Compartment Models in Individual and Population Analysis
Quantitative Aspects of Drug-Receptor Interaction